CYTOTOXIC IMMUNE CELLS WITH SPECIFICITY FOR DEFINED SOLUBLE ANTIGENS : IV. ANTIBODY AS MEDIATOR OF SPECIFIC CYTOTOXICITY by Schirrmacher, Volker et al.
CYTOTOXIC  IMMUNE  CELLS  WITH  SPECIFICITY  FOR DEFINED 
SOLUBLE  ANTIGENS 
IV.  ANTIBODY AS  MEDIATOR  OF  SPECIFIC  CYTOTOXICITY* 
BY VOLKER SCHIRRMACHER,~;  BENT RUBIN,§ HUGH PROSS, I  ] AND 
HANS WIGZELL 
(From the Department o.f Tumorbiology,  Karolinska Institute,  Stockholm,  Sweden) 
(Received for publication 21 August 1973) 
In an attempt to study model systems for allograft and tumor immunity, a number 
of in vitro cell-mediated cytotoxic systems have been investigated. Depending on the 
cytotoxic system studied, different types of cells, e.g. T  lymphocytes, B lymphocytes, 
or macrophages, have been found  to be involved in specific target cell destruction 
(see reference 1). Little is known about the parameters which determine the type of 
effector cell(s) that will function in a  given experimental situation. Also, the mech- 
anisms that lead to target cell destruction in the various systems and their possible 
in vivo interactions are poorly understood. In view of this complex situation, it seems 
desirable to start with the analysis of highly reproducible and well-defined systems. 
In  recent  studies,  we  have  investigated an  in  vitro cytotoxic system with  spe- 
cificity for defined soluble antigens. It has previously been found in an experimental 
autoimmune situation that red cells coated with soluble protein antigen can function 
as target cells for antigen specific cytolytic in vitro reactions (2). The present system 
consists of  spleen cells from  mice  that have  been  immunized against conventional 
soluble antigens, such as heterologous proteins or hapten-carrier conjugates, and of 
51Cr-labeled  target  cells  (chicken  red  blood  cells,  CRBC)  to  which  the  respective 
antigens had been covalently attached (3). Cell-fractionation studies (4, 5) have re- 
vealed that the lytic effector cell in this system is neither an antigen-specific T  cell 
(as tested by helper function) nor an antigen-specific B  cell (as tested by antibody- 
forming cell precursor function)  and  that  it has distinct adherence properties (see 
reference 6).  Greenberg et al.  (7),  working with antibody-coated CRBC  and  non- 
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immune mouse spleen cells, demonstrated that in their system the effector cells were 
membrane-Ig negative as  well as  0-antigen negative.  These  effector  ceils  could  be 
separated from other cells and were characterized as monocyte-like cells.  1 
The  present  paper  reports  investigations on  the  mechanism  that  leads  to 
specific lysis of the antigen-coated target cells by immune spleen cells. Little is 
known about  what  confers  specificity on monocyte- or macrophage-mediated 
cytotoxicity. Among the different factors that have been suggested are: specific 
macrophage-arming factor  (SMAF,  8,  9),  which might be a  T  cell product  (9, 
10),  and cytophilic antibody (11,  12).  Evidence will be presented that  specific 
cytotoxicity  in  our  system  is  mediated  through  specific  antibody,  which  is 
produced by the immune cells, and which interacts with the target cell antigens 
through  its  combining sites.  The  interaction  of  antibody with  the  cytotoxic 
effector cells will be analyzed in the following report3 
Materials and Methods 
The materials and methods used in the cytotoxie system have been described in detail 
previously (3-5)  and therefore  only a brief description will be given. 
Mice and Immunization.--2-3-mo  old CBA mice were  used throughout the experiments. 
They were immunized subcutaneously with 0.1 ml antigen solution (1 mg/ml) emulsified in an 
equal volume of complete Freund's adjuvant (CFA). 
Preparation of Antigen-Coated and 51Cr-Labeled Target Cdls.--O.1 ml of a 50% suspension 
of washed fresh CRBC was added to 3 ml of phosphate-buffered saline (PBS), pH 7.4, con- 
raining 35 mg albumin antigen. 0.35 ml of a  solution of  1-ethyl-3-(3-dimethylaminopropyl) 
¢arbodiimide-HC1  (ECDI, 200 mg/ml) was added and the cells were incubated for 1 h at room 
temperature. They were then washed four times in PBS and tested for the presence of mem- 
brane-bound antigen using specific antisera and the passive hemagglutination microtest. For 
labeling with  51Cr, about 107 Ag-CRBC in 0.2 ml PBS were incubated with  150/zCi Na2 
51CRO4 (1 mCi/ml) for 3-4 h at room temperature. The labeled cells were washed twice with 
culture medium (Medium F13, containing 10% heat-inactivated fetal calf serum, penicillin, 
and streptomycin) and adjusted to a concentration of 105 cells/ml. 
Test for Cell-Mediated Cytotoxicity.--The  cytotoxic test was carried  out in Wassermann 
plastic test tubes (11 X 55 mm), each of which contained 5 X  104 51Cr-labeled Ag-CRBC and 
varying amounts of immune or nonirnmune  spleen cells (see the corresponding ratio for each 
experiment) in a volume of 1 ml culture medium. Depending on the experiment, antibody or 
inhibitors were added to the incubation mixtures. Their final concentrations are indicated in 
each experiment. After incubation  for about 18 h at 37°C in a 5o-/0 CO2 atmosphere, the tubes 
were centrifuged and 0.5-ml aliquots of the supernatants removed. The radioactivity of the 
pellet and residual supernatant and the radioactivity of the 0.5-ml supernatant sample were 
measured in a well-type scintillation counter. After subtraction of the background, a release 
index (R.I.) was calculated: 
radioactivity of the supernatant 
R.I.  =  ;K 100. 
total radioactivity 
1 A. It.  Greenberg, L.  Shen, and I.  M.  Roitt.  1973. Characterization of  the  antibody- 
dependent cytotoxic cell: a non-phagocytic monocyte? Clin. Exp. Immunol. 1.5-251. 
2 V. Schirrmaeher, B. Rubin, and H. Pross. 1973. Cytotoxic immune cells with specificity 
for  defined  soluble antigens. V. Analysis of  the interaction of antibody with the cytotoxic 
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The results are expressed as R.I. minus spontaneous release of target cells alone. Each value 
given is the mean of the figures obtained for three test tubes. The intragroup  variance for a 
given experiment has been computed from the R.I. of all the test tubes. Use has been made of 
this variance to calculate the difference that would be significant (P  =  0.05) in a student's 
t test between two experimental groups in the experiment. 
Preparation and Use of Anti-lg or Control Columns.--The preparation  of glass bead columns 
coated with a polyvalent  rabbit antimouse immunoglobulin serum  (anfi-Ig column) or with 
normal  rabbit serum  (control column) has been described  (13). Sera or supernatants  were 
absorbed on the columns by passing them through at room temperature  and at a flow rate of 
about 1 ml/min.  The eluates were concentrated  to the original volume by negative pressure 
dialysis. 
Separation of 19S and 7S Antibodies.--19S and 7S antibodies were separated  by sucrose 
gradient centrifugafion as described previously (14). 
RESULTS 
Absence  of  Carrier  Specifici,y.--The  secondary  anti-DNP  response  to  di- 
nitrophenylated mouse serum albumin (DM) in mice shows the phenomenon of 
carrier  specificity  (15),  while  the  anti-DNP  antibodies  induced  are  hapten 
specific (16).  3 In order to evaluate the specificity characteristics of the cytotoxic 
reaction of DM-immune cells the role of the carrier molecule was investigated. 
The results in Table I  show that DM-immune cells display the same degree of 
cytotoxicity to  CRBC  coated with  dinitrophenylated  bovine serum  albumin 
(DB) as to CRBC-DM, while they are not cytotoxic to CRBC-OA. Since there 
is no cross-reactivity between the carrier determinants on DM and DB  (16), it 
is  concluded  that  the  cytotoxic reaction  of DM-immune  cells  is  not  carrier 
specific. 
Inhibition of Cytotoxicity by Soluble Antigen or ttapten.--We further investi- 
gated the specificity of the cytotoxic system by inhibition experiments using as 
inhibitors free soluble antigen or hapten. Table II shows two such experiments. 
DM- and OA-immune cells were incubated in the presence or absence of either 
DNP-lysine (exp. I) or OA (exp. II) together with CRBC-DM, CRBC-DB, or 
CRBC-OA as  target  cells.  Specific  and  complete  inhibition  was  observed  in 
both  instances,  and  the  existence  of  hapten-specific  cytotoxicity  is  clearly 
demonstrated  (exp. I). 
The data in Table II show differences in the amount of OA or DNP-lysine 
that  inhibited  the  respective  cytotoxic  system.  On  a  molar  basis,  about  a 
hundred times more DNP-lysine was needed to get the same degree of inhibition 
as with OA. When the serum antibodies of the OA- and DM-immune animals 
that were donating the immune cytotoxic cells were analyzed by passive hemag- 
glufination inhibition, similar differences in the location of the inhibition curves 
were  observed  (Fig.  1).  With  increasing  time  after  immunization  both  cyto- 
toxicity  inhibition  curves  and  antibody  inhibition  curves  shifted  to  lower 
antigen or hapten concentrations. From these data it is apparent that the cyto- 
3 See Discussion section concerning  the immune  response against  new  antigenic  deter- 
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TABLE  I 
Absence of Carrier Specificity of DM-Immune Cell Cytotoxicity 
Target cell  S.R.* 
Cytotoxicity$ of immune cells§ 
Anti-DM  Anti-OA 
150:1  75:1  25:1  150:1  75:1  25:1 
CRBC-DM  7  35  26  20  5  9  7 
CRBC-DB  8  37  28  23  9  9  10 
CRBC-OA  7  6  5  7  37  30  23 
* Spontaneous 51Cr release (S.R.) from target cells incubated alone. 
Expressed as release index minus S.R. 
§The immune spleen cells  (3  wk)  were incubated with the target cells at the indicated 
ratios; the smallest difference that would be significant (P  =  0.05)  in a  t  test between two 
figures was 4.6. 
TABLE  II 
Inhibition  of Immune Cell Cytotoxicity by Free Hapten or Antigen 
II 
Target cell 
CRBC-DM 
CRBC-DB 
CRBC-OA 
CRBC-DM 
CRBC-OA 
F13 
5  42 
8  39 
6  6 
F13 
4  40 
5  7 
-8 
37 
39 
5 
--9 
Cytotoxicity:~ of immune  cells§ 
Anti-DM  ___ 
-6  I  -4  F13 
16  8  4 
21  9P  3 
2  3  49 
--8  --7  F13 
--  42  9 
--  5  44 
I 
-8 
-9 
32 
Anti-OA 
-6 
3 
40 
-8 
16  I 
-4 
3 
42 
-7 
7 
7 
Inhibitorl[ 
DNP-lysine 
OA 
* Spontaneous ~lCr release (S.R.)  of target cells incubated alone. 
Expressed as release index minus S.R. 
§ Immune spleen cells,  4  wk  (exp.  I)  or 2 wk  (exp.  II)  after immunization with 100/zg 
DM or OA; the ratio of immune to target cells was 150:1. The smallest difference that would 
be significant (P  =  0.05)  in a t test between two figures was 3.5  (exp. I) and 5.5  (exp. II). 
--, not done. 
[[ The inhibitors were present during the whole incubation period (18 h). The logl0 molar 
inhibitor concentration in the final incubation mixture is indicated in the respective hori- 
zontal line. F13 means medium without inhibitor. 
toxicity inhibition curves reflect  the avidity or affinity  (in the case of OA and 
DNP-lysine  respectively) of the serum antibodies in the same animals. 
Induction  of Cytotoxicity  in  Nonimmune  Spleen  Cells  by  Target  Cell-Bound 
Serum  Antibodies.--Fig.  2  illustrates  an  experiment  in  which  specific  cyto- 
toxicity  was  observed  (a)  with  immune  spleen  cells,  and  (b)  with  immune V.  SCHIRRMACHER,  B. RUBIN,  H. PROSS,  AND  H. WIGZELL  97 
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Fzo.  1.  Inhibition of antibody activity  (A) and of immune cell cytotoxicity  (B) by free 
soluble antigen or hapten. A Antibody activity in the sera from animals immunized 2 weeks 
(open symbols) or 6 weeks (closed symbols) before with 100 #g OA (triangles) or DM (circles) 
was determined by passive hemagglutination inhibition using SRBC-OA or CRBC-DM  as 
indicator ceils. The logs titers for the pooled sera from three animals per group were: anti-OA 
(2 wk) 6.5; anti-OA (6 wk) 11.5; anti-DM (2 wk) 5.5; and anti-DM (6 wk) 5.5. Passive hemag- 
glutination inhibition was carried out by titrating the sera in PBS containing OA or DNP- 
lysine respectively as inhibitors. B  cytotoxicity of  the immune spleen ceils from  the same 
animals was determined using SlCr-labeled CRBC-OA or CRBC-DM as target ceils. The ratio 
of immune to target ceils was 150:1. The specific cytotoxicity in the absence of OA or DNP- 
lysine as inhibitors was: anti-OA (2 wk) 28%; anti-OA (6 wk)  33%; anti-DM  (2 wk)  57%; 
and anti-DM (6 wk) 49%. The smallest difference that would be significant (P  =  0.05) in a 
t test between two points was 2.6. >- 
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FIG. 2.  Cytotoxicity of either OA-immune spleen cells (7 wk, circles)  or of anfi-0A anti- 
serum from the same animals in presence of nonimmune spleen cells (= normal cells, triangles). 
The target cells were CRBC-OA (open symbols) and CRBC-HSA (solid symbols). The ratio of 
nonimmune spleen cells to target cells was 100:1. No specific cytotoxicity was observed with 
anti-OA antiserum at the indicated concentrations in the absence of nonimmune spleen cells. 
The smallest difference that would be significant (P =  0.05) in a t test between two points was 
4.9. 
serum from the same animals in the presence of nonimmune spleen cells. Cyto- 
toxicity increased  with  increasing  ratios  of immune  to  target  cells  4 as well as 
with  increasing  amounts  of  antiserum  (starting  at  a  dilution  of  10  -7)  at  a 
constant ratio of nonimmune cells to target cells (100:1). While minute amounts 
of  antiserum  (10-4-10  -5  diluted)  induced  optimal  cytotoxicity,  higher  con- 
centrations  ( >  10  ~) usually had a  suppressive effect. 
In order to characterize  the nature  of the cytotoxicity inducing factor in the 
immune  serum,  the  antiserum  was  absorbed  on  an  anti-Ig  or  on  a  control 
column.  The results  (Table III)  show that  anti-OA antiserum  absorbed  on an 
4 In earlier experiments  (3)  we observed a  linear increase of cytotoxicity with  increasing 
ratios of immune to target cells only up to a ratio of about S0:1. It was now possible to show 
that the suppression or relative reduction of eytotoxicity at higher ratios was due to the cen- 
trffugation of the tubes before the incubation period. This step, which increased the sensitivity 
of the system at low ratios, was omitted in the experiments reported in this paper. V.  SCI-IIRRMACHER~  B.  RUBIN, H.  PROSS~ AND H.  WIGZELL  99 
TABLE III 
Cytotoxicity of Nonimmune Spleen Cells in the Presence of Antiserum Absorbed on anti-Ig or 
Control Columns 
Cytotoxicity:~ of nonimmnne spleen cells in presence of anti-OA 
antiserum§ which was 
Target cell  S,R. * 
Unfractionated  Absorbed on an anti-lg  Absorbed on a  control 
column  column 
10  TM  10  -6  10-*  10  -6  10  TM  10  .-6 
CRBC-OA  10  57  39  14  1  54  16 
CRBC-HSA  10  0  0  1  1  3  0 
* Spontaneous  51Cr release (S.R.) from target cells incubated  alone. 
:~ Expressed as release index minus S.R. 
§ Antiserum  (inactivated 30 rain at 56°C) from mice that had been immunized 6 mo before 
with  100/zg  OA in Freund's complete adjuvant.  Its log2 passive  hemagglution  titer with 
CRBC-OA was 9, after anti-Ig column absorbtion  1.5 and after control  column absorbtion 8. 
The final dilution of the antiserum in the test is indicated. The ratio of spleen cells to target 
cells was 150:1. The smallest difference that would be significant (P  =  0.05) in a t test be- 
tween two figures was 4.1. 
anfi-Ig column was by a  factor of about  one hundred  less  active in  inducing 
specific cytotoxicity in comparison with the same serum absorbed on a  control 
column. These results  indicate the immunoglobulin nature of the cytotoxicity 
inducing factor in the immune serum. 
Induction  of Cytotoxicity  in  Nonimmune  Spleen  Cells  by Supernatants from 
Immune  Cell  Cultures.--The  fact  that  serum  antibodies  bound  to  Ag-CRBC 
target cells induced cytotoxicity in nonimmune spleen cells does not necessarily 
mean that the present immune cell cytotoxic system functions according to the 
same principle,  i.e.  through the involvement of specific antibodies.  In order to 
elucidate this point an attempt was made to directly demonstrate specific cyto- 
toxicity  inducing  antibody  activity  in  the  supernatants  of  our  immune  cell 
cultures. Fig. 3 shows the positive outcome of such an experiment. DB-immune 
spleen cells were incubated in vitro under the conditions of the cytotoxic test, 
but  in  the  absence  of target  cells,  and  the  supernatants  from fourteen  such 
cultures  were  pooled.  DNP  specific  cytotoxicity could  be  conferred  on  non- 
immune spleen cells by these supernatants,  as well as by their q,-globulin frac- 
tions,  provided,  of  course,  that  DNP-coated  target  cells  were  added  to  the 
system  to  demonstrate  the  effect  (Fig.  3 A  and  Fig.  3 B).  Supernatants  ab- 
sorbed on an anti-Ig column were inactive (Fig. 3 C). It is thus shown that the 
immune spleen cells produce antibody in vitro in quantites sufficient to induce 
cytotoxicity in  nonimmune  spleen  cells.  Since  we have  also  shown  that  the 
immune cell cytotoxic system has the specificity and affinity characteristics of 
serum  antibodies  (see  above),  we  would  conclude  that  cytotoxicity  in  our 
immune cell system is in fact mediated through specific antibodies. 
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FI~. 3.  Cytotoxicity of supernatants from DB-immune cell cultures in presence of non- 
immune spleen cells and CRBC-DM (white columns) or uncoated CRBC  (black columns) as 
target cells.  The ratio of nonimmune spleen cells to  target cells was 100:1.  4  X  107  DB- 
immune cells  (4 wk) were incubated in i ml culture medium for 18 h  at 37°C in a  50-/o CO2 
atmosphere. The supernatants of fourteen such cultures were pooled. The T-globulin fraction 
was prepared from a sample (7 ml) by two successive precipitations with half saturated am- 
monium sulfate, with extensive dialysis against saline in between and afterwards. Another 
sample of the supernatant was absorbed on a  glass bead column coated with rabbit anti- 
mouse Ig antiserum. 
toxici~y.--The next step in  the analysis of the Ag-CRBC lytic system was to 
investigate whether  the  ability of antibodies  to mediate specific cytotoxicity 
was restricted to a certain class (19S/7S) of antibodies. Fig. 4 shows the results 
of  several  experiments.  19S  and  7S  anti-DNP  antisera  which  had  the  same 
passive hemagglutination  titer  were  titrated  in  the  presence  of  nonimmune 
spleen cells and CRBC-DM  (white columns) or CRBC-OA (black columns) as 
target cells. While 19S antibodies from whole sera or from a 19S sucrose gradient 
fraction were virtually inactive in the cytotoxic test (Fig. 4 A),  7S antibodies 
from whole sera or from a  7S sucrose gradient  fraction were very efficient in 
inducing cytotoxicity (Fig. 4 B). 
DISCUSSION 
Antibody-dependent cell-mediated cytolytic systems have been described in 
a  number of instances,  where antibody complexed target cells were incubated V.  SCHIRRMACHER,  B.  RUBIN,  H.  PROSS,  AND  H.  WIGZELL  101 
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FIG. 4.  Cytotoxicity of nonimmune spleen cells in presence of 19S (A) or 7S (B) anti-DNP' 
antibodies  and CRBC-DM  (white columns) or CRBC-OA  (black columns) as target cells. 
The ratio of spleen cells to target cells was 100:1. The DNP-specific hemagghitination  titers. 
of the different antibody fractions, indicated on the right part, were tested with DNP-HSA- 
SRBC.  While the  19S antibody titers  were sensitive  to reduction  with 0.2 M  2-mercapto- 
ethanol,  the 7S titers were reduction resistant.  19S antisera  were obtained from mice 9 days, 
(first column) or 13 days (second and third column) after a single intraperitoneal  injection ofl 
100 #g DNP60-BGG. The third column shows the activity of a 19S sucrose gradient fraction. 
7S antisera were obtained from mice 6 wk (first column) or 6 mo (second column) after im- 
munization  with  100 #g DNP12-BGG  in Freund's complete adjuvant.  The second column 
shows the activity of a 7S sucrose gradient fraction. All sera were inactivated  30 rain at 56°C. 
in vitro with nonimmune lymphoid cells. Mostly xenogeneic systems have been 
studied  (17-19)  but allogeneic  (20,  21)  and syngeneic (autoimmune,  reference 
22, and tumor immune reference 23) systems have been described as well. The 
cytolytic effector cells  in  these  systems  are  believed  not  to  belong  to  the T 
lymphocytes  (see references  24 and  25).  It has not yet been  demonstrated  if 
immune  cell  cytolytic systems  can function  according to  the same principle, 
i.e.  through  a  cooperation  between  an  antibody-producing  system  and  non- 
immune  effector cells.  Synergistic  and  antagonistic  effects of antibody  on in 
vitro  immune  cell  cytotoxicity  have  been  described  (26-28).  The  only  safe 
conclusion that has been reached so far is that there exist in the immune system 
at  least  two  alternative  cell-mediated  cytolytic pathways,  one  involving  T 
lymphocytes (13, 29), the other non-T lymphoid or other cells (3, 31, 34). The 
exact nature  of  the  latter  effector cells  is  still  under  discussion.  Non-T  cell- 
mediated  cytotoxicity has been  attributed  to any type of non-T  cell-bearing 
membrane-bound  Fe receptors: purified lymphocytes (18,  35),  B  cells  (19,  25, 
31, 36, 37) ; macrophages (11, 38-40); monocytes (41) ;1 polymorphonuclear cells 
(42); and also to a  new type of cell (4345).  Some of the studies that involved 
the use of anti-Ig sera  (31, 36) for characterizing the effector cells might have 102  ANTIBODY  AS  MEDIATOR  OF  IMMUNE  CELL  CYTOTOXICITY 
been  misleading,  because  inhibition  of  cytotoxicity might  have  reflected  a 
blocking of Fo receptors via anti-Ig-Ig complexes rather than a direct effect on 
the effector cell  surface structures  (see references 4, 7, and 24). 2 Since the F, 
receptors  on lymphocytes and monocytes differ in  their specificities for IgG 
subclasses  (46,  47)  aggregated myeloma proteins of different subclasses have 
been used in inhibition experiments in order to clarify whether the effector cells 
belong to the lymphocyte or to the monocyte lineage of cells.  Unfortunately, 
different results have been obtained in different systems. The cytotoxic effector 
cells in the human peripheral blood showed subclass specificity characteristics of 
lymphocytes (45,  48),  while in mouse spleen cells  the cytotoxic effector cells 
shared the subclass specificities with the monocytes.  ~ It therefore seems that 
depending on the cytotoxic system studied, different types of non-T cells may 
become  activated  by  antibody-coated target  cells  to  function  as  cytotoxic 
effector cells. 
The present immune cell cytotoxicity system has certain advantages as com- 
pared with others:  (a)  it is generally applicable to the study of cytotoxic re- 
sponses using any kind of soluble antigen (3), 5 (b) the target cell membrane is 
relatively stable (3),  reducing the risk of production of inhibitory complexes; 
(c)  the exact control of specificity is made possible by using the same type of 
target cell coated with different antigens; and (d) it is also possible to do fine 
specificity studies and even affinity or avidity analysis through inhibition by 
defined soluble antigens. 
In the present study, three lines of evidence were obtained for the involvement 
of specific antibodies in the immune cell cytotoxicity system: (a) ])M-immune 
cell  cytotoxicity has been shown to be hapten specific  (Tables I  and II) and 
thus to follow the specificity characteristics of anti-DNP antibodies rather than 
of cellular immune responses  (see reference 50).  No specificity was found for 
the new antigenic determinants (NAD's, reference 16) introduced into the autol- 
ogous  protein  by the hapten-coupling reaction. This is due to the fact  that 
NAD's were not expressed on the CRBC-])M target cells, probably due to the 
carbodiimide-coupling reaction  (V.  Schirrmacher and B.  Rubin, unpublished 
observations).  (b) The cytotoxicity inhibition curves obtained in the presence 
of  either free  hapten  (DNP-lysine in  case of DM-immune  cells)  or  soluble 
antigen (OA in case of OA-immune cells)  reflected the affinity or avidity re- 
spectively of the  serum antibodies from  the  same animals.  Cytotoxicity in- 
inhibition curves and antibody inhibition curves were at a  similar position in 
both the DNP and the OA system, and both shifted with increasing time after 
immunization towards lower inhibitor concentrations (Fig. 1). (c) Supernatants 
from in vitro immune cell cultures contained an antigen-specific factor, which, 
like serum antibodies (Fig.  2 and Table III), induced cytotoxicity in nonim- 
mune spleen cells when specific  target cells were added. This supernatant ac- 
5  The system has already been successfully  applied for studies on autoimmune  thyroiditis 
(2, 49). V.  SCttlRRMACHER,  B.  RUBIN,  H.  PROSS,  AND  1t.  WIGZELL  103 
tivity was recovered in the "r-globulin  fraction, and was absorbed on columns 
coated with polyvalent antimouse immunoglobulin serum (Fig. 3). 
Thus, specificity is conferred on the effector cells in  the  immune cytolytic 
system by antibodies, which are produced during the incubation period of the 
test. We have no evidence for antibodies being brought into the system from 
the beginning, e.g. in form of cytophilic antibodies that were attached to cell 
surfaces (12), but we do know that cytotoxicity  in the immune cell system starts 
only after a lag period of about 3 h, while in presence of antibodies it would start 
immediately.  2 Other evidence for the dependency of the immune cell cytotoxic 
system on active antibody synthesis in vitro comes from studies of MacLennan 
and Harding  (51)  who showed that their immune cell  cytotoxic system was 
inhibited in presence of puromycin while the nonimmune cell system was not 
affected. 
The ability of target cell-bound antibody to induce cytotoxicity in nonim- 
mune spleen cells was restricted to the 7S antibody class (Fig. 4).  Similar re- 
sults have been obtained in other antibody-dependent cell-mediated cytotoxic 
systems (52, 53).  It is difficult to explain why 19S antibodies were inactive in 
this cytolytic test, especially considering the fact that macrophages do possess a 
receptor for 19S antibodies (54). 
SUMMARY 
Spleen ceils from mice immunized against ovalbumin (OA) or dinitrophenyl- 
ated mouse  serum albumin  (DM)  were found to be specifically cytotoxic in 
vitro towards target cells  (chicken red blood cells)  coated with these antigens. 
Inhibition of specific cytotoxicity was observed when free soluble antigen was 
added  to  the  incubation  mixtures.  DM-immune  cell  cytotoxicity could  be 
specifically and completely inhibited by DNP-lysine and was thus shown to be 
hapten  specific.  Complete and specific  inhibition was  also observed for OA- 
immune cell  cytotoxicity using OA as inhibitor,  but  compared with the in- 
hibition curves obtained with DNP-lysine, the OA cytotoxicity  inhibition curves 
were shifted by a  factor of about one hundred towards lower molar inhibitor 
concentrations. Very similar results were observed when the serum antibodies 
of DM- and OA-immune animals were analyzed by passive hemagglutination 
inhibition.  With  increasing  time  after  immunization,  both  cytotoxicity in- 
hibition curves and agglutination inhibition curves, shifted to lower antigen or 
hapten concentrations. 
Specific cytotoxicity against antigen-coated target cells was induced in non- 
immune spleen cells  (a)  by serum from immune animals, and  (b)  by super- 
natants from in vitro immune cell cultures. In both instances, the factor which 
induced antigen-specific cytotoxic activity could be absorbed on anti-mouse Ig 
columns, thus demonstrating its immunoglobulin nature. The ability of target 
cell bound antibodies to induce cytotoxicity in nonimmune spleen cells was re- 
stricted to the 7S antibody class. 
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